Published in Graefes Arch Clin Exp Ophthalmol on July 01, 2011
Interventions for the treatment of uveitic macular edema: a systematic review and meta-analysis. Clin Ophthalmol (2013) 1.02
Pharmacokinetics, electrophysiological, and morphological effects of the intravitreal injection of mycophenolic acid in rabbits. J Ocul Pharmacol Ther (2014) 0.80
Birdshot chorioretinopathy: current knowledge and new concepts in pathophysiology, diagnosis, monitoring and treatment. Orphanet J Rare Dis (2016) 0.78
Morphological assessment of the retina in uveitis. J Ophthalmic Inflamm Infect (2016) 0.75
Quality of Life Outcomes from a Randomized Clinical Trial Comparing Antimetabolites for Intermediate, Posterior, and Panuveitis. Am J Ophthalmol (2017) 0.75
[Therapy of intermediate uveitis]. Ophthalmologe (2014) 0.75
Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol (2005) 13.50
International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol (1987) 5.13
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol (2000) 4.70
Mycophenolate mofetil and its mechanisms of action. Immunopharmacology (2000) 3.41
Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study. BMJ (2009) 2.23
Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology. Ann Rheum Dis (2002) 1.85
Uveitis: a potentially blinding disease. Ophthalmologica (2004) 1.80
Mycophenolate mofetil. A useful immunosuppressive in inflammatory eye disease. Ophthalmology (1999) 1.66
Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence. Am J Ophthalmol (2008) 1.56
Mechanisms of action of mycophenolate mofetil. Lupus (2005) 1.49
Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation. Ophthalmology (2008) 1.46
Mycophenolate mofetil therapy for inflammatory eye disease. Ophthalmology (2005) 1.46
Mycophenolate mofetil for ocular inflammation. Am J Ophthalmol (2009) 1.41
Rescue therapy with mycophenolate mofetil in refractory uveitis. Lancet (1998) 1.09
Mycophenolate mofetil as an immunomodulatory agent in the treatment of chronic ocular inflammatory disorders. Ophthalmology (2003) 1.07
Mycophenolate mofetil for the treatment of uveitis. Am J Ophthalmol (2008) 1.04
Mycophenolate mofetil in the treatment of uveitis in children. Br J Ophthalmol (2006) 1.02
Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis. Ophthalmology (2008) 1.01
Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis : a retrospective analysis of 106 patients. Graefes Arch Clin Exp Ophthalmol (2005) 1.00
Long-term efficacy of mycophenolate mofetil in the control of severe intraocular inflammation. Clin Experiment Ophthalmol (2003) 0.93
Mycophenolate mofetil therapy for sarcoidosis-associated uveitis. Ocul Immunol Inflamm (2009) 0.91
Mycophenolate sodium for immunosuppressive treatment in uveitis. Ocul Immunol Inflamm (2009) 0.81
[Efficiency of mycophenolate mofetil in the treatment of intermediate and posterior uveitis]. Ophthalmologe (2002) 0.79
[Mycophenol acid in ocular automimmune disorders--can we optimise this therapy?]. Klin Monbl Augenheilkd (2008) 0.76
Long-term remission after cessation of interferon-α treatment in patients with severe uveitis due to Behçet's disease. Arthritis Rheum (2010) 1.84
Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials. Ophthalmology (2013) 1.81
The natural course of gross motor deterioration in metachromatic leukodystrophy. Dev Med Child Neurol (2011) 1.55
Adalimumab in the therapy of uveitis in childhood. Br J Ophthalmol (2006) 1.47
The use of interferon alpha in Behçet disease: review of the literature. Semin Arthritis Rheum (2004) 1.44
Older patients fare better with the Ross operation. Ann Thorac Surg (2003) 1.40
Understanding uveitis: the impact of research on visual outcomes. Prog Retin Eye Res (2011) 1.35
Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis. Ophthalmology (2010) 1.34
Strengths and weaknesses of diagnostic tools for tuberculous uveitis. Ocul Immunol Inflamm (2009) 1.25
The use of positron emission tomography/CT in the diagnosis of tuberculosis-associated uveitis. Br J Ophthalmol (2010) 1.25
Efficacy and safety of anakinra therapy in pediatric and adult patients with the autoinflammatory Muckle-Wells syndrome. Arthritis Rheum (2011) 1.22
Behçet's disease: ocular effects and treatment. Prog Retin Eye Res (2007) 1.17
Differential efficacy of human recombinant interferon-alpha2a on ocular and extraocular manifestations of Behçet disease: results of an open 4-center trial. Semin Arthritis Rheum (2004) 1.17
Rosacea - S1 guideline. J Dtsch Dermatol Ges (2013) 1.06
Benefit from tonsillectomy in adult patients with chronic tonsillitis. Eur Arch Otorhinolaryngol (2006) 1.05
Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis : a retrospective analysis of 106 patients. Graefes Arch Clin Exp Ophthalmol (2005) 1.00
Weak transient response of chronic uveitic macular edema to intravitreal bevacizumab (Avastin). Graefes Arch Clin Exp Ophthalmol (2007) 1.00
Development of cerebral blood flow volume in preterm neonates during the first two weeks of life. Pediatr Res (2005) 0.99
Acute laparoscopic intervention for diverticular disease (AIDD): a feasible approach. Langenbecks Arch Surg (2008) 0.99
Risk factors for severe Muckle-Wells syndrome. Arthritis Rheum (2010) 0.98
Hemoglobin A1c is a reliable criterion for diagnosing type 1 diabetes in childhood and adolescence. Pediatr Diabetes (2010) 0.98
Trends in epidemiology and patho-anatomical pattern of proximal humeral fractures. Int Orthop (2014) 0.96
Controversies in ocular toxoplasmosis. Ocul Immunol Inflamm (2011) 0.96
Health and quality of life in adults with Noonan syndrome. J Pediatr (2012) 0.94
Perioperative outcome of patients with esophageal atresia and tracheo-esophageal fistula undergoing open versus thoracoscopic surgery. J Laparoendosc Adv Surg Tech A (2011) 0.94
Development and reliability of a classification system for gross motor function in children with metachromatic leucodystrophy. Dev Med Child Neurol (2010) 0.93
[Successful topical cyclosporin A in the therapy of progressive vascularising keratitis in keratitis-ichthyosis-deafness (KID) syndrome (Senter syndrome)]. Klin Monbl Augenheilkd (2002) 0.91
Current strategies for the treatment of proximal humeral fractures: an analysis of a survey carried out at 348 hospitals in Germany, Austria, and Switzerland. J Shoulder Elbow Surg (2012) 0.90
Uveitis in children. Int Ophthalmol Clin (2005) 0.90
New shift models for doctors in a large German University Neurosurgery Department: how they comply with the European Working Time Directive 3 years after implementation. Acta Neurochir (Wien) (2012) 0.89
Quality of life after unilateral acoustic neuroma surgery via middle cranial fossa approach. Acta Otolaryngol (2005) 0.88
Comparison of four microwave ablation devices: an experimental study in ex vivo bovine liver. Radiology (2013) 0.88
Factors influencing the duration of late first and second-trimester termination of pregnancy with prostaglandin derivates. Eur J Obstet Gynecol Reprod Biol (2010) 0.88
Interferon-α therapy in noninfectious uveitis. Dev Ophthalmol (2012) 0.88
Is the Ross operation still an acceptable option in children and adolescents? Ann Thorac Surg (2006) 0.88
Prognostic value and therapeutic consequences of vascular invasion in non-small cell lung carcinoma. Lung Cancer (2008) 0.88
Treatment and outcome of patients suffering from perineal/perianal rhabdomyosarcoma: results from the CWS trials--retrospective clinical study. Ann Surg (2014) 0.88
Perioperative outcome of patients with congenital diaphragmatic hernia undergoing open versus minimally invasive surgery. J Laparoendosc Adv Surg Tech A (2012) 0.87
Impact of gender, age, and comorbidities on quality of life in patients with chronic rhinosinusitis. Rhinology (2007) 0.87
Interferon alfa-2a: a new treatment option for long lasting refractory cystoid macular edema in uveitis? A pilot study. Retina (2006) 0.86
Treatment of Muckle-Wells syndrome: analysis of two IL-1-blocking regimens. Arthritis Res Ther (2013) 0.86
Efficacy of post-operative analgesia after posterior lumbar instrumented fusion for degenerative disc disease: a prospective randomized comparison of epidural catheter and intravenous administration of analgesics. Orthop Rev (Pavia) (2010) 0.86
Immunomodulatory therapy with tumour necrosis factor α inhibitors in children with antinuclear antibody-associated chronic anterior uveitis: long-term results. Br J Ophthalmol (2014) 0.86
Human recombinant interferon-alpha2a (rhIFN alpha2a) for the treatment of Behçet's disease with sight-threatening retinal vasculitis. Adv Exp Med Biol (2003) 0.85
Behçet's disease in patients of German and Turkish origin living in Germany: a comparative analysis. J Rheumatol (2004) 0.85
A single-institution experience with the Ross operation over 11 years. Ann Thorac Surg (2009) 0.85
Treatment efficiency, outcome and surgical treatment problems in patients suffering from localized embryonal bladder/prostate rhabdomyosarcoma: a report from the Cooperative Soft Tissue Sarcoma trial CWS-96. Pediatr Blood Cancer (2010) 0.85
Vogt-Koyanagi-Harada disease. Ocul Immunol Inflamm (2014) 0.84
Impact of gender on general health-related quality of life in patients with chronic sinusitis. Am J Rhinol (2005) 0.83
Impact of genotype and mutation type on health-related quality of life in patients with hereditary hemorrhagic telangiectasia. Acta Otolaryngol (2009) 0.83
Current medical treatment of ocular mucous membrane pemphigoid. Ocul Surf (2013) 0.83
Effect of verteporfin photodynamic therapy on endostatin and angiogenesis in human choroidal neovascular membranes. Br J Ophthalmol (2006) 0.82
Impact of risk factors for prolonged operative time in laparoscopic cholecystectomy. Eur J Gastroenterol Hepatol (2012) 0.82
Treatment of ocular rosacea with once-daily low-dose doxycycline. Cornea (2014) 0.82
POST-TEXT III and IV Hepatoblastoma: Extended Hepatic Resection Avoids Liver Transplantation in Selected Cases. Ann Surg (2017) 0.81
Mycophenolate sodium for immunosuppressive treatment in uveitis. Ocul Immunol Inflamm (2009) 0.81
Interferon-alpha-associated presumed ocular sarcoidosis. Graefes Arch Clin Exp Ophthalmol (2008) 0.81
Relationships of body composition and liver fat content with insulin resistance in obesity-matched adolescents and adults. Obesity (Silver Spring) (2014) 0.81
Coronary artery bypass grafts: assessment of graft patency and native coronary artery lesions using 16-slice MDCT. Eur Radiol (2006) 0.81
Amphotericin B in the therapy of Candida glabrata endophthalmitis after penetrating keratoplasty. Cornea (2006) 0.81
Measuring wearing times of glasses and ocular patches using a thermosensor device from orthodontics. Acta Ophthalmol (2013) 0.81
Controversies in Behçet disease. Ocul Immunol Inflamm (2012) 0.80
The creeping choroiditides - serpiginous and multifocal serpiginoid choroiditis. Ocul Immunol Inflamm (2014) 0.80
The good, the bad and the ugly--APCs of the eye. Trends Immunol (2003) 0.80
Intraocular lymphoma: more questions than answers. Ocul Immunol Inflamm (2009) 0.79
High incidence of antibodies to lens proteins in sera from patients with uveitis. Graefes Arch Clin Exp Ophthalmol (2006) 0.79
Necrotizing herpetic retinitis. Ocul Immunol Inflamm (2014) 0.79
Therapy of uveitis in children. Int Ophthalmol Clin (2008) 0.79
An unusual case of central serous chorioretinopathy in a patient with acute retinal necrosis. Ocul Immunol Inflamm (2008) 0.79
Influence of interferon-alpha on lymphocyte subpopulations in Behçet's disease. Adv Exp Med Biol (2003) 0.78
Interferon-a (IFN-a) application versus tumor necrosis factor-a antagonism for ocular Behçet's disease: focusing more on IFN. J Rheumatol (2005) 0.78
[Evaluation of benchmarking networks in Germany: background and methodology]. Z Evid Fortbild Qual Gesundhwes (2011) 0.78
Successful treatment of chronic pseudophakic macular edema (Irvine-Gass syndrome) with interferon alpha: a report of three cases. Ocul Immunol Inflamm (2011) 0.78
Reference levels of insulin-like growth factor I in the serum of healthy adults: comparison of four immunoassays. Clin Chem Lab Med (2003) 0.78
The complexity of proximal humeral fractures is age and gender specific. J Orthop Sci (2013) 0.78
Interferon alpha 2a in IRPB-derived peptide-induced EAU--part I. Adv Exp Med Biol (2003) 0.78
Controversies in ocular inflammation and immunology laser flare photometry. Ocul Immunol Inflamm (2010) 0.78
Sporadic Blau syndrome with onset of widespread granulomatous dermatitis in the newborn period. Pediatr Dermatol (2010) 0.78
Presumed tuberculosis-induced retinal vasculitis, diagnosed with positron emission tomography (18F-FDG-PET/CT), aspiration biopsy, and culture. Ocul Immunol Inflamm (2010) 0.78
Attenuated expression of apoptosis stimulating protein of p53-2 (ASPP2) in human acute leukemia is associated with therapy failure. PLoS One (2013) 0.77
Identification of immunodominant epitopes of alpha-crystallins recognized by antibodies in sera of patients with uveitis. Graefes Arch Clin Exp Ophthalmol (2011) 0.77
Tumor biology influences the prognosis of nephroblastoma patients with primary pulmonary metastases: results from SIOP 93-01/GPOH and SIOP 2001/GPOH. Ann Surg (2011) 0.77
Uveitis treatment trials--a cross-study perspective. Ocul Immunol Inflamm (2012) 0.77
NOD2 mutations are associated with the development of intestinal failure in the absence of Crohn's disease. Clin Nutr (2013) 0.77